BI 695502

BI 695502 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BI 695502, covering 2019-11-08 to 2020-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer [Phase 3]